F. Charbonnier, S. Penad e´ s
FULL PAPER
2
.00, 1.99, 1.96 (s, 12 H, 4 ϫ CH
3
CO), 1.94 (br. s, 3 H, CH
β
Ada), 5.31Ϫ5.29 (m, 1 H, H-2), 5.06 (dd, J ϭ 10.2, J ϭ 3.6 Hz, 1 H, H-
1.73Ϫ1.46 (m, 12 H, CH
2
Ada) ppm. 13C NMR (CDCl
3
, 125 MHz):
CO), 90.1 (C-1), 80.8, H-5), 3.25 (d, J ϭ 9.3 Hz, 1 H, CH
2.7, 72.2, 71.8, 71.6, 71.0, 68.9, 68.3, 62.2, 62.1 (C-2, C-3, C-4, C- H, CH OAda), 2.14, 2.04, 1.97 (s, 9 H, 3 ϫ CH
, C-6), 39.4, 37.0, 33.8, 28.1, 20.7, 20.6 (CH CO) ppm. MALDI- H, CHAda), 1.74Ϫ1.48 (m, 12 H, CH Ada), 1.12 (d, J ϭ 6.6 Hz,
) ppm. C NMR (125 MHz, CDCl ): δ ϭ 170.6, 170.5,
170.2 (CH CO), 96.5 (C-1), 79.1, 71.2 (C-2), 68.6, 68.4 (C-4, C-3),
4.0 (C-5), 39.4, 39.0, 37.2, 37.1; 28.2, 28.1, 20.8, 20.6 (CH CO),
5.9 (CH ) ppm. MALDI-TOF: calcd. 461.50 [C23 ϩ Na];
3), 4.98 (d, J ϭ 3.9 Hz, 1 H, H-1), 4.10 (br. q, J ϭ 12.3 Hz, 1 H,
OAda), 2.87 (d, J ϭ 9.6 Hz, 1
CO), 1.95 (br. s, 3
δ ϭ 170.7, 170.3, 169.8, 169.4, 169.2 (CH
7
5
3
2
2
3
3
2
ϩ
ϩ
13
TOF: m/z ϭ 520.0 [M ϩ Na ϩ H] , 536.0 [M ϩ K ϩ H] .
10 (496.56): calcd. C 60.41, H 7.25; found C 60.30, H 7.15.
3 H, CH
3
3
C
25
H
36
O
3
6
1
3
1-Adamantylmethyl 2,3,4,6-Tetra-O-acetyl-β- -glucopyranoside
D
3
34 8
H O
1
(5b): H NMR (500 MHz, CDCl ): δ ϭ 5.17 (t, J ϭ 10 Hz, 1 H,
3
ϩ
ϩ
found 461.7 [M ϩ Na] , 477.6 [M ϩ K] .
H-3), 5.05 (t, J ϭ 10 Hz, 1 H, H-4), 4.98 (dd, J ϭ 7.5, J ϭ 10 Hz,
H, H-2), 4.39 (d, J ϭ 7.5 Hz, 1 H, H-1), 4.24 (dd, J ϭ 7.5, J ϭ 1-Adamantylmethyl 2,3,4-Tri-O-acetyl-β- H
.5 Hz, 1 H, H-6a), 4.10 (dd, J ϭ 10, J ϭ 4.5 Hz, 1 H, H-6b), NMR (300 MHz, CDCl ): δ ϭ 5.24Ϫ5.17 (m, 2 H, H-4, H-2), 5.00
.67Ϫ3.61 (m, 1 H, H-5), 3.47 (d, J ϭ 10 Hz, 1 H, CH OAda),
(dd, J ϭ 10.5, JH3,H4 ϭ 3.3 Hz, 1 H, H-3), 4.35 (d, J ϭ 8.1 Hz, 1
L
-fucopyranoside (7b): 1
1
4
3
2
3
2
.95 (d, J ϭ 10 Hz, 1 H, CH
2
OAda), 2.06, 2.02, 1.99, 1.98 (s, 12 H, H1), 3.77 (br. q, J ϭ 12.3 Hz, 1 H, H-5), 3.53 (d, J ϭ 9.6 Hz,
Ada) ppm. 1 C NMR 1 H, CH
3
OAda), 2.95 (d, J ϭ 9.6 Hz, 1 H, CH
OAda), 2.17, 2.05,
H, 4 ϫ CH
3
CO), 1.72Ϫ1.44 (m, 12 H, CH
2
2
2
(
CDCl3, 125 MHz): δ ϭ 170.6, 170.1, 169.6 (CH
3
CO), 96.1 (C-1),
9.2, 71.1, 70.4, 68.7, 66.9, 61.9 (C-2, C-3, C-4, C-5, C-6), 39.4, (m, 12 H, CH
7.0, 33.8, 28.1, 20.7, 20.6 (CH CO) ppm. MALDI-TOF: m/z ϭ
1.98 (3s, 9 H, 3 ϫ CH
3
CO), 1.95 (br. s, 3 H, CHAda), 1.73Ϫ1.49
1
3
7
3
5
6
2
Ada), 1.21 (d, J ϭ 6.3 Hz, 3 H, CH
3
) ppm.
C
NMR (125 MHz, CDCl
10 (496.56): calcd. C 102.4(C-1), 81.0, 71.3, 70.4, 69.2, 69.0 (C-2, C-3, C-4, C-5), 39.5,
39.3, 37.2, 37.1, 33.9, 28.2, 28.1, 20.8, 20.7, 20.6 (CH CO), 16.1
3 3
): δ ϭ 170.8, 170.3, 169.4 (COCH ),
3
ϩ
ϩ
36
19.7 [M ϩ Na] , 535.7 [M ϩ K] . C25H O
0.41, H 7.25; found C 60.10, H 7.15.
3
ϩ
(
CH
3
) ppm. MALDI-TOF: m/z ϭ 461.9 [M ϩ Na] , 477.9
1
(
-Adamantylmethyl 2,3,4,6-Tetra-O-acetyl-α/β-D-galactopyranoside
ϩ
[M ϩ K] .
6a,b): Starting from penta-O-acetyl--galactopyranose (500 mg) a
mixture of 6a and 6b was obtained (50%, α/β, 1:2) as a white solid. 1-Adamantylmethyl
The mixture was chromatographed on silica gel (ethyl acetate/hex-
(8a): Starting from penta-O-acetyl--mannopyranose (200 mg)
ane, 1:4) to give the α-anomer 6a (105 mg) and the β-anomer 6b only the α-isomer 8a was obtained (136m g, 65%). R (ethyl acetate/
): δ ϭ 5.37Ϫ5.22
2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoside
f
1
(200 mg) as white solids. R
f
(ethyl acetate/hexane, 1:2) ϭ 0.50 (α),
hexane, 1:2) ϭ 0.52. H NMR (300 MHz, CDCl
3
0
.45 (β).
(m, 3 H, H-2, H-3, H-4), 4.74 (br. s, 1 H, H-1), 4.27 (dd, J ϭ 12.3,
J ϭ 5.4 Hz, 1 H, H-6a), 4.11 (dd, J ϭ 12.3, J ϭ 2.4 Hz, 1 H, H-
1-Adamantylmethyl 2,3,4,6-Tetra-O-acetyl-α-
D
-galactopyranoside
6
2
b), 4.00Ϫ3.90 (m, 1 H, H-5), 3.27 (d, J ϭ 9 Hz, 1 H, CH
.97 (d, J ϭ 9 Hz, 1 H, CH OAda), 2.16, 2.11, 2.05, 2.00 (4s, 12
CO), 1.98 (br. s, 3 H, CHAda), 1.78Ϫ1.50 (m, 12 H,
Ada) ppm. 13C NMR (125 MHz, CDCl
): δ ϭ 170.6 (COCH ),
8.3 (C-1), 86.9, 79.2, 70.0, 69.7, 68.7, 66.7, 62.9 (C-2, C-3, C-4, C-
, C-6, CAda), 39.9, 37.4, 28.4 (CH CO) ppm. MALDI-TOF:
2
OAda),
1
(6a): H NMR (500 MHz, CDCl
3
): δ ϭ 5.46 (dd, J ϭ 3.3, J ϭ 1.2
2
Hz, 1 H, H-4), 5.28 (dd, J ϭ 10.5, J ϭ 3 Hz, 1 H, H-3), 5.04 (dd,
J ϭ 10.5, J ϭ 3 Hz, 1 H, H-2), 5.01 (d, J ϭ 3 Hz, 1 H, H-1),
H, 4 ϫ CH
CH
9
5
3
2
3
3
4
6
1
2
1
.14Ϫ4.12 (m, 1 H, H-5), 4.07 (dd, J ϭ 11.0, J ϭ 6 Hz, 1 H, H-
a), 4.02 (dd, J ϭ 11.0, J ϭ 6.0 Hz, 1 H, H-6b), 3.23 (d, J ϭ 9 Hz,
H, CH
.00, 1.95 (s, 12 H, 4 ϫ CH
.70Ϫ1.59 (m, 6 H, CH Ada), 1.48 (br. s, 6 H, CH
3
ϩ
ϩ
2
OAda), 2.86 (d, J ϭ 9.5 Hz, 1 H, CH
CO), 1.93 (br. s, 3 H, CHAda),
Ada) ppm.
2
OAda), 2.09, 2.01,
m/z ϭ 518.4 [M ϩ Na Ϫ H] , 534.3 [M ϩ K Ϫ H] . C25
496.55): calcd. C 60.50, H 7.30; found C 60.10, H 7.55.
36 10
H O
3
(
2
2
ϩ
Zempl e´ n Deacetylation: A solution of sodium methoxide in meth-
anol (1 , 0.1 equiv.) was added at room temperature to a solution
of the acetylated 1-adamantylmethyl glycosides (1.0 equiv.) in
methanol. After 2 h, the mixture was neutralised with Amberlite
resin IRA-120, the solution was filtered and the solvents were eva-
porated to give the corresponding 1-adamantylmethyl glycoside.
MALDI-TOF: m/z ϭ 520.4, [M ϩ Na ϩ H] , 536.4 [M ϩ K ϩ
H] . C25
H 6.95.
ϩ
36
H O10 (496.56): calcd. C 60.41, H 7.25; found. C 60.37,
1
-Adamantylmethyl 2,3,4,6-Tetra-O-acetyl-β-
D
-galactopyranoside
): δ ϭ 5.37Ϫ5.35 (m, 1 H, H-4),
.20 (dd, J ϭ J ϭ 8 Hz, 1 H, H-2), 4.99 (dd, J ϭ 10.5, J ϭ 3.5 Hz,
1
(6b): H NMR (500 MHz, CDCl
3
5
1
1
1-Adamantylmethyl α-
D-Glucopyranoside (1a): From 5a (325 mg,
H, H-3), 4.36 (d, J ϭ 8 Hz, 1 H, H1), 4.16 (dd, J ϭ 11, J ϭ 7 Hz,
H, H-6a), 4.10 (dd, J ϭ 11, J ϭ 7 Hz, 1 H, H-6b), 3.85 (m, 1 H,
1
.0 equiv.) in methanol (50 mL). 1a was obtained as a white solid
2
5
(
98%). R
f
1
(CH
2
Cl
2
/MeOH, 98:2) ϭ 0.29. [α]
D
ϭ 5.98 (c ϭ 1.0,
H-5), 3.49 (d, J ϭ 9.5 Hz, 1 H CH
CH OAda), 2.13, 2.04, 2.03, 1.96 (s, 12 H, 4 ϫ CH
s, 3 H, CHAda), 1.71Ϫ1.58 (m, 6 H, CH Ada), 1.48 (br. s, 6 H,
Ada) ppm. 13C NMR (125 MHz, CDCl
CH ): δ ϭ 97.9 (C-1), 78.0,
7
3
5
2
OAda), 2.96 (d, 1 H,
MeOH). H NMR (300 MHz, CD
3
OD): δ ϭ 4.71 (d, J ϭ 3.6 Hz,
2
3
CO), 1.93 (br.
1
H, H-1), 3.80 (dd, J ϭ 11.7, J ϭ 2.4 Hz, 1 H, H-6a), 3.71Ϫ3.63
2
(m, 2 H, H-3, H-6b), 3.61Ϫ3.55 (m, 1 H, H-5), 3.40 (dd, J ϭ 9.9,
J ϭ 3.9 Hz, 1 H, H-2), 3.36 (m, 1 H, H-4), 3.27 (d, J ϭ 9.0 Hz, 1
2
3
0.2, 69.2, 68.9, 68.3, 60.7 (C-2, C-3, C-4, C-5, C-6a, C-6b), 38.7,
6.2, 32.8, 27.5 ppm. MALDI-TOF: m/z ϭ 520.2 [M ϩ Na ϩ H] ,
36.3 [M ϩ K ϩ H] . C25H O10 (496.56): calcd. C 60.41, H 7.25;
36
ϩ
H, CH
3 H, CH
(
7
2
OAda), 2.94 (d, J ϭ 9.3 Hz, 1 H, CH
Ada), 1.81Ϫ1.75 (m, 12 H, CH Ada) ppm. C NMR
125 MHz, CD OD): δ ϭ 101.1 (C-1), 80.4, 76.0, 74.7, 74.4, 72.8,
3.6 (C-2, C-3, C-4, C-5, C-6), 41.6, 39.1, 30.6 ppm. MALDI-TOF:
2
OAda), 1.98 (br. s,
1
3
ϩ
β
2
found C 59.89, H 7.23.
3
ϩ
ϩ
1
-Adamantylmethyl 2,3,4-Tri-O-acetyl-α/β-
L
-fucopyranose (7a,b):
17 28 6
m/z ϭ 351 [M ϩ Na] , 367 [M ϩ K] . C H O (328): calcd. C
Starting from tetra-O-acetyl--fucopyranose (632 mg) a mixture of 62.0, H 8.5; found. C 61.9, H 7.81.
7
a and 7b was obtained (65%, α/β 6:1). R
f
(ethyl acetate/hexane,
1
-Adamantylmethyl β-
D
-Glucopyranoside (1b): From 5b (49 mg) in
(CH Cl
ϭ Ϫ21.7 (c ϭ 0.64, MeOH). H NMR
OD, 500 MHz): δ ϭ 4.20 (d, J ϭ 8.5 Hz, H-1), 3.93 (m, 1 H,
H-6a), 3.73 (dd, J ϭ 12.0, J ϭ 5.5 Hz, 1 H, H-6b), 3.56 (d, J ϭ
): δ ϭ 5.33 (d, J ϭ 3.3 Hz, 1 H, H-4), 10.0 Hz, 1 H, CH OAda), 3.50 (t, J ϭ 8.5 Hz, 1 H, H-3), 3.48Ϫ3.43
1:2) ϭ 0.66 (α), 0.50 (β). The mixture was chromatographed on
methanol (20 mL). 1b (99%) was obtained as a syrup. R
f
2
2
/
silica gel (ethyl acetate/hexane, 1:4) to give the α-anomer 7a
237 mg) and the β-anomer 7b (35 mg) as white solids.
2
5
1
MeOH, 98:2) ϭ 0.30. [α]
CD
D
(
(
3
1
1-Adamantylmethyl 2,3,4-Tri-O-acetyl-α- -fucopyranoside (7a): H
L
NMR (300 MHz, CDCl
3
2
3654
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
Eur. J. Org. Chem. 2004, 3650Ϫ3656